z-logo
open-access-imgOpen Access
Effect of laser acupuncture on adhesive small bowel obstruction
Author(s) -
ChiJen Shih,
Ting-Min Hsieh,
Bei-Yu Wu,
ChunTing Liu
Publication year - 2021
Publication title -
medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.59
H-Index - 148
eISSN - 1536-5964
pISSN - 0025-7974
DOI - 10.1097/md.0000000000025035
Subject(s) - medicine , randomized controlled trial , motilin , bowel obstruction , acupuncture , surgery , anesthesia , alternative medicine , pathology
Abstract Background: Adhesive small bowel obstruction (ASBO) is one of the most common complications and is a major cause of re-admission after intra-abdominal surgery. The initial management of patients with ASBO is nonoperative treatment such as nil per os and decompression using a nasogastric tube. However, the ideal management of ASBO remains controversial. Methods: This study will be a prospective, single-center, double-blind randomized controlled trial. Ninety two participants diagnosed with ASBO will be randomly assigned to either the verum or the sham laser acupuncture (SLA) group in a 1:1 ratio. All participants will undergo laser acupuncture (LA) or SLA once a day on 6 acupoints (LI4, PC6, ST25, ST36, CV4 and CV12) for 6 consecutive days after enrollment. The primary outcome measure will be the success rate of conservative treatment for ASBO. Secondary outcomes will be time to oral intake and length of hospital stay. The serum levels of lipase, amylase, cortisol, motilin, ghrelin, and intestinal fatty acid binding protein (I-FABP) will also be measured before intervention, on day 4, and on the day of discharge, respectively. Data will be analyzed by Chi-Squared test or t test between 2 groups. Objectives: The aim of this protocol is to investigate the clinical efficacy of LA on ASBO. Trial registration: ClinicalTrials.gov Identifier: NCT04318821. Registered on 24 March 2020.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here